Related Experiment Video
Updated: Mar 12, 2026
06:26
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
3.2K
Novel approaches to tuberculosis vaccine development
Stefan H E Kaufmann1, January Weiner1, C Fordham von Reyn2
1Max Planck Institute for Infection Biology, Department of Immunology, Charitéplatz 1, 10117 Berlin, Germany.
Summary
Tuberculosis (TB) is a deadly infectious disease. This review summarizes new TB vaccine developments, as current options like the bacille Calmette-Guérin (BCG) vaccine offer limited protection.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Tuberculosis (TB) remains a leading cause of infectious disease mortality globally.
- The existing bacille Calmette-Guérin (BCG) vaccine provides inconsistent and limited protection against TB.
- There is an urgent need for more effective TB vaccines.
Purpose of the Study:
- To review current developments in novel tuberculosis (TB) vaccine candidates.
- To provide an overview of emerging strategies in TB vaccinology.
- To highlight advancements beyond the traditional BCG vaccine.
Main Methods:
- Literature review of recent research and clinical trials on TB vaccines.
- Synthesis of information on various vaccine platforms and approaches.
- Analysis of preclinical and clinical data for new TB vaccine candidates.
Main Results:
- Several promising TB vaccine candidates are under development, including subunit, inactivated whole-cell, and live mycobacterial vaccines.
- New vaccine strategies aim to overcome the limitations of BCG.
- Ongoing research focuses on improving efficacy and broadening protection against TB.
Conclusions:
- The landscape of TB vaccine development is dynamic, with diverse approaches being explored.
- Advancements in vaccinology offer hope for improved TB control strategies.
- Continued research and development are crucial to achieving a highly effective TB vaccine.
Keywords:
Post-exposure vaccinePre-exposure vaccinePreventive vaccineSubunit vaccineTherapeutic vaccineWhole-cell vaccineMore Related Videos
Related Concept Videos
01:26Pulmonary Tuberculosis IV
600
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
600
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:28Pulmonary Tuberculosis V
726
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
726
01:28Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
01:31Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K